Showing results (161-170 of 19,456) with videos related to

Sort By:
Pageof 1,946
Lancet (London, England)|January 11, 2025
Efficacy, safety, and target engagement of dazukibart, an IFNβ specific monoclonal antibody, in adults with dermatomyositis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trialDavid Fiorentino, Aaron R Mangold, Victoria P Werth, et al.
Lancet (London, England)|March 6, 2025
Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
Lancet (London, England)|March 6, 2025
Global, regional, and national prevalence of adult overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
Lancet (London, England)|March 13, 2025
A multifaceted intervention to improve diagnosis and early management of hospitalised patients with suspected acute brain infections in Brazil, India, and Malawi: an international multicentre intervention studyBhagteshwar Singh, Gareth D Lipunga, Premkumar Thangavelu, et al.
Lancet (London, England)|November 13, 2025
The effects of government-led cash transfer programmes on behavioural and health determinants of mortality: a difference-in-differences studyAaron Richterman, Tra-My Ngoc Bùi, Elizabeth F Bair, et al.
Lancet (London, England)|November 14, 2025
Safety and efficacy of weekly pemvidutide versus placebo for metabolic dysfunction-associated steatohepatitis (IMPACT): 24-week results from a multicentre, randomised, double-blind, phase 2b studyMazen Noureddin, Stephen A Harrison, Rohit Loomba, et al.
Lancet (London, England)|January 19, 2025
Radiotherapy toxicities: mechanisms, management, and future directionsIoannis I Verginadis, Deborah E Citrin, Bonnie Ky, et al.
Lancet (London, England)|November 21, 2025
Policies to halt and reverse the rise in ultra-processed food production, marketing, and consumptionGyorgy Scrinis, Barry M Popkin, Camila Corvalan, et al.
Lancet (London, England)|November 23, 2025
Preoperative mFOLFIRINOX versus PAXG for stage I-III resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): results of the first randomisation analysis of a randomised, open-label, 2 × 2 factorial phase 3 trialMichele Reni, Marina Macchini, Giulia Orsi, et al.
Lancet (London, England)|November 16, 2025
Hyperemesis gravidarumMelanie Nana, Rebecca Painter, Catherine Williamson, et al.
Pageof 1,946